578 related articles for article (PubMed ID: 34838731)
1. Enhancing preclinical drug discovery with artificial intelligence.
Vijayan RSK; Kihlberg J; Cross JB; Poongavanam V
Drug Discov Today; 2022 Apr; 27(4):967-984. PubMed ID: 34838731
[TBL] [Abstract][Full Text] [Related]
2. Application of Artificial Intelligence and Machine Learning in Drug Discovery.
Gupta RR
Methods Mol Biol; 2022; 2390():113-124. PubMed ID: 34731466
[TBL] [Abstract][Full Text] [Related]
3. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery.
Yang X; Wang Y; Byrne R; Schneider G; Yang S
Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972
[TBL] [Abstract][Full Text] [Related]
4. The potential applications of artificial intelligence in drug discovery and development.
Farghali H; Kutinová Canová N; Arora M
Physiol Res; 2021 Dec; 70(Suppl4):S715-S722. PubMed ID: 35199553
[TBL] [Abstract][Full Text] [Related]
5. Good machine learning practices: Learnings from the modern pharmaceutical discovery enterprise.
Makarov V; Chabbert C; Koletou E; Psomopoulos F; Kurbatova N; Ramirez S; Nelson C; Natarajan P; Neupane B
Comput Biol Med; 2024 Jul; 177():108632. PubMed ID: 38788373
[TBL] [Abstract][Full Text] [Related]
6. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors.
Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C
Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning and Artificial Intelligence: A Paradigm Shift in Big Data-Driven Drug Design and Discovery.
Pasrija P; Jha P; Upadhyaya P; Khan MS; Chopra M
Curr Top Med Chem; 2022; 22(20):1692-1727. PubMed ID: 35786336
[TBL] [Abstract][Full Text] [Related]
8. New avenues in artificial-intelligence-assisted drug discovery.
Cerchia C; Lavecchia A
Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
[TBL] [Abstract][Full Text] [Related]
9. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
Koromina M; Pandi MT; Patrinos GP
OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
[TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence and machine learning for clinical pharmacology.
Ryan DK; Maclean RH; Balston A; Scourfield A; Shah AD; Ross J
Br J Clin Pharmacol; 2024 Mar; 90(3):629-639. PubMed ID: 37845024
[TBL] [Abstract][Full Text] [Related]
11. Artificial intelligence revolutionizing drug development: Exploring opportunities and challenges.
Tiwari PC; Pal R; Chaudhary MJ; Nath R
Drug Dev Res; 2023 Dec; 84(8):1652-1663. PubMed ID: 37712494
[TBL] [Abstract][Full Text] [Related]
12. Opportunities and challenges in application of artificial intelligence in pharmacology.
Kumar M; Nguyen TPN; Kaur J; Singh TG; Soni D; Singh R; Kumar P
Pharmacol Rep; 2023 Feb; 75(1):3-18. PubMed ID: 36624355
[TBL] [Abstract][Full Text] [Related]
13. Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development.
Sarkar C; Das B; Rawat VS; Wahlang JB; Nongpiur A; Tiewsoh I; Lyngdoh NM; Das D; Bidarolli M; Sony HT
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768346
[TBL] [Abstract][Full Text] [Related]
14. CADD, AI and ML in drug discovery: A comprehensive review.
Vemula D; Jayasurya P; Sushmitha V; Kumar YN; Bhandari V
Eur J Pharm Sci; 2023 Feb; 181():106324. PubMed ID: 36347444
[TBL] [Abstract][Full Text] [Related]
15. Artificial Intelligence (AI) in Drugs and Pharmaceuticals.
Sahu A; Mishra J; Kushwaha N
Comb Chem High Throughput Screen; 2022; 25(11):1818-1837. PubMed ID: 34875986
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions.
Vatansever S; Schlessinger A; Wacker D; Kaniskan HÜ; Jin J; Zhou MM; Zhang B
Med Res Rev; 2021 May; 41(3):1427-1473. PubMed ID: 33295676
[TBL] [Abstract][Full Text] [Related]
17. Industrializing AI/ML during the end-to-end drug discovery process.
Yoo J; Kim TY; Joung I; Song SO
Curr Opin Struct Biol; 2023 Apr; 79():102528. PubMed ID: 36736243
[TBL] [Abstract][Full Text] [Related]
18. The application of artificial intelligence to accelerate G protein-coupled receptor drug discovery.
Nguyen ATN; Nguyen DTN; Koh HY; Toskov J; MacLean W; Xu A; Zhang D; Webb GI; May LT; Halls ML
Br J Pharmacol; 2024 Jul; 181(14):2371-2384. PubMed ID: 37161878
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on recent approaches for cancer drug discovery associated with artificial intelligence.
Pandiyan S; Wang L
Comput Biol Med; 2022 Nov; 150():106140. PubMed ID: 36179510
[TBL] [Abstract][Full Text] [Related]
20. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
